1-3 of 3
Elizabeth P. Nacheva
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions

Clinical Trials & Observations
Brian J. P. Huntly, Francois Guilhot, Alistair G. Reid, George Vassiliou, Evelin Hennig, Christina Franke, Jennie Byrne, Andre Brizard, Dietger Niederwieser, Julie Freeman-Edward, Gavin Cuthbert, Nick Bown, Richard E. Clark, Elizabeth P Nacheva, Anthony R Green, Michael W. N. Deininger
Journal: Blood
Blood (2003) 102 (6): 2205–2212.
https://doi.org/10.1182/blood-2002-09-2763
Published: 2003
Journal Articles

Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instability

Brian J. P. Huntly, Anthony J. Bench, Eric Delabesse, Alistair G. Reid, Juan Li, Mike A. Scott, Lynda Campbell, Jennie Byrne, Eleanor Pinto, Andre Brizard, Deitger Niedermeiser, Elizabeth P. Nacheva, Francois Guilhot, Michael Deininger, Anthony R. Green
Journal: Blood
Blood (2002) 99 (12): 4547–4553.
https://doi.org/10.1182/blood.V99.12.4547
Published: 2002
Journal Articles

Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia

Clinical Trials & Observations
Brian J. P. Huntly, Alistair G. Reid, Anthony J. Bench, Lynda J. Campbell, Nick Telford, Patricia Shepherd, Jeff Szer, H. Miles Prince, Paul Turner, Colin Grace, Elizabeth P. Nacheva, Anthony R. Green
Journal: Blood
Blood (2001) 98 (6): 1732–1738.
https://doi.org/10.1182/blood.V98.6.1732
Published: 2001